Intradermal Phleum pratense allergoid immunotherapy. Double-blind, randomized, placebo-controlled trial.

Francisco Javier Sola MartínezRuth María Barranco JiménezCristina Martín GarcíaCarlos Senent SánchezCarlos Blanco GuerraMontserrat Fernández-RivasArantza Vega CastroIgnacio Dávila GonzálezAntonio Carbonell MartínezCarmen Panizo BravoElisa Gómez Torrijos David Rodríguez GilRicardo Palacios Peláez

Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2020)

Intradermal immunotherapy with P pratense allergoid has been shown to be effective and safe, reducing CSMS, increasing tolerance to the conjunctival provocation test and reducing IgE levels.

Keyphrases

double blind
placebo controlled
clinical trial
phase iii
phase ii
study protocol
randomized controlled trial